Patent 7348306 was granted and assigned to Fuso Pharmaceutical Industries,Ltd. on March, 2008 by the United States Patent and Trademark Office.
A composition for promoting lacrimal secretion which can be used safely and effectively in the lacrimal secretion promoting therapy, not in the conventional supplemental therapy of lacrimal fluid components is provided. The composition comprises a component which activates PAR-2. Also, a contact lens which retains and/or contains said composition for promoting lacrimal secretion is provided.